Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit

Biol Blood Marrow Transplant. 2003 Nov;9(11):722-4. doi: 10.1016/j.bbmt.2003.09.001.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Biological Availability
  • Busulfan / administration & dosage
  • Busulfan / pharmacokinetics
  • Busulfan / toxicity*
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Injections, Intravenous
  • Reproducibility of Results

Substances

  • Antineoplastic Agents, Alkylating
  • Busulfan